Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Awaiting price reaction for this filing.
Citurgia Biochemicals has informed BSE that its Board of Directors will meet on Thursday, 14 August 2025 to consider and approve the unaudited standalone financial results for the quarter ended 30 June 2025 (Q1 FY26). The company has also flagged that any other business as per the agenda may be taken up. The trading window for insiders has been closed since 1 July 2025 and will reopen 48 hours after the results are announced to the stock exchange. This is a routine regulatory filing under SEBI LODR Regulation 29, with no financial details disclosed at this stage.
No direct impact on shareholders or stock price from this intimation alone; investors should wait for the actual Q1 FY26 results on 14 August 2025 for any meaningful trading signals. The closed trading window simply means insiders cannot trade until after results are published.